Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
136 studies found for:    glioblastoma | Open Studies | Phase 2
Show Display Options
Rank Status Study
1 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
2 Recruiting Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: PQR309
3 Recruiting Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma;   Recurrent Glioblastoma;   Brain Tumor
Intervention: Drug: Tesevatinib
4 Not yet recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Drug: Neratinib;   Drug: CC-115;   Drug: Abemaciclib
5 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
6 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
7 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide
8 Recruiting Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: G-202
9 Recruiting Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: SRT to the resection cavity
10 Not yet recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
11 Recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
12 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
13 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia;   Glioblastoma
Intervention: Drug: Romiplostim
14 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
15 Not yet recruiting Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: levetiracetam
16 Recruiting Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Interventions: Radiation: Stereotactic hypofractionated RT 5x5Gy;   Radiation: Stereotactic hypofractionated RT 5x7Gy
17 Recruiting Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Atorvastatin;   Drug: Temozolomide;   Radiation: Radiotherapy
18 Recruiting Regorafenib in Relapsed Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Regorafenib;   Drug: Lomustine
19 Recruiting Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Sunitinib;   Drug: Temozolomide;   Radiation: Radiation Therapy
20 Recruiting Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Ponatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.